Related Articles Using Agency Nurses to Fill RN Vacancies Within Specialized Hospice and Palliative Care. Policy Polit Nurs Pract. 2016 Aug;17(3):147-155 Authors: Cozad MJ, Lindley LC, Mixer SJ Abstract The use of agency nurses offers flexibility in filling registered nurse (RN) openings during times of shortage, yet little is known about their use in specialized palliative care. In an effort to fill this knowledge gap, this study determined whether significant relationships existed between full-time and part-time RN vacancies and the use of agency RNs within specialized hospices that deliver perinatal end-of-life care to women and their families in the event…
Origen: Using Agency Nurses to Fill RN Vacancies Within Specialized Hospice and Palliative Care. – PubMed

Related Articles Do we have adequate tools and skills to manage uncertainty among patients and families in ICU? Intensive Care Med. 2017 Mar;43(3):463-464 Authors: Harding R, Hopkins P, Metaxa V, Higginson IJ PMID: 27933344 [PubMed – indexed for MEDLINE]
Origen: Do we have adequate tools and skills to manage uncertainty among patients and families in ICU? – PubMed

Related Articles Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017 Jan – Feb;7(1):4-12 Authors: Lutz S, Balboni T, Jones J, Lo S, Petit J, Rich SE, Wong R, Hahn C Abstract PURPOSE: The purpose is to provide an update the Bone Metastases Guideline published in 2011 based on evidence complemented by expert opinion. The update will discuss new high-quality literature for the 8 key questions from the original guideline and implications for practice. METHODS AND MATERIALS: A systematic PubMed search from the last date included in the original Guideline yielded 414 relevant…
Origen: Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. – PubMed

Related Articles Supportive care in pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2017 Nov;19(11):1293-1302 Authors: Laquente B, Calsina-Berna A, Carmona-Bayonas A, Jiménez-Fonseca P, Peiró I, Carrato A Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the cancers with poorest prognosis and represents the third leading cause of cancer-related deaths in Western countries. Despite advances in diagnostic procedures and treatment, diagnosis is made in most cases when the disease is locally advanced or metastatic. Supportive care aims to improve symptoms, reduce hospital admission rates, and preserve quality of life. Proper symptomatic management is critical to allow administration of chemotherapy and radiotherapy. Symptomatic…
Origen: Supportive care in pancreatic ductal adenocarcinoma. – PubMed

Related Articles Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation. J Appl Clin Med Phys. 2016 Nov 08;17(6):6375 Authors: Salek N, Shamsaei M, Ghannadi Maragheh M, Shirvani Arani S, Bahrami Samani A Abstract Skeletal uptake of radiolabeled-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetramethylene phosphoric acid (e.g., 177Lu-DOTMP) complex, is used for bone pain palliation. The moderate energy of β-emitting 177Lu (T½ = 6.7 d, Eβmax = 497keV) has been considered as a potential radionuclide for development of the bone-seeking radiopharmaceutical. Since the specific activity of the radiolabeled carrier molecules should be high, the «no-carrier-added…
Origen: Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation. – PubMed